Drug Profile
CIN 101
Alternative Names: CIN-101Latest Information Update: 28 Dec 2021
Price :
$50
*
At a glance
- Originator CinRx Pharma
- Class Skin disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Skin disorders